Affinage

CLCN4

H(+)/Cl(-) exchange transporter 4 · UniProt P51793

Length
760 aa
Mass
84.9 kDa
Annotated
2026-04-28
32 papers in source corpus 18 papers cited in narrative 18 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CLCN4 encodes ClC-4, a vesicular 2Cl⁻/H⁺ antiporter that acidifies endosomal compartments to support transferrin receptor recycling, iron release, and copper incorporation into ceruloplasmin (PMID:16034421, PMID:19339555, PMID:15057754). When expressed alone, ClC-4 is retained in the endoplasmic reticulum via an N-terminal targeting motif (aa 14–63), but heterodimerization with ClC-3 splice variants redirects it to recycling endosomes or late endosomes/lysosomes, with ClC-3–ClC-4 heterodimers being more stable than ClC-4 homodimers (PMID:17023393, PMID:28972156). The accessory protein TMEM9B directly interacts with and inhibits ClC-4 transporter activity, providing an additional layer of regulation (PMID:39202776). Pathogenic CLCN4 variants cause X-linked neurodevelopmental disease including epilepsy and developmental encephalopathy through loss-of-function, gain-of-function, or dominant-negative mechanisms within ClC-3/ClC-4 heterodimers (PMID:36385166, PMID:35721313, PMID:41439993).

Mechanistic history

Synthesis pass · year-by-year structured walk · 13 steps
  1. 1999 High

    Establishing that ClC-4 directly conducts strongly outwardly rectifying anion currents with a defined selectivity sequence resolved whether the protein was itself an ion-conducting entity or merely a regulator.

    Evidence Xenopus oocyte and HEK293 electrophysiology with site-directed mutagenesis (E224A)

    PMID:9873029

    Open questions at the time
    • Transport stoichiometry and whether H⁺ coupling occurs were not addressed
    • Native cellular context not tested
  2. 2002 High

    Detailed biophysical characterization revealed that ClC-4 requires ATP for full activity and is inhibited by extracellular acidification, establishing regulatory parameters relevant to endosomal function.

    Evidence Patch-clamp electrophysiology with single-channel recordings and nucleotide substitution in mammalian cells

    PMID:11882671

    Open questions at the time
    • Whether ATP acts directly on the protein or through a signaling intermediate was not resolved
    • Physiological relevance of pH inhibition in endosomes not yet tested
  3. 2003 Medium

    Localization of ClC-4 to endosomal membranes and demonstration that its depletion alkalinizes endosomal pH and impairs transferrin trafficking established ClC-4 as a functionally important endosomal transporter.

    Evidence Confocal microscopy, antisense knockdown, endosomal pH measurement, and co-immunoprecipitation with ClC-5

    PMID:12746443

    Open questions at the time
    • Antisense approach lacks genetic specificity
    • Co-IP with ClC-5 not validated by reciprocal pull-down or in-vivo crosslinking
  4. 2004 Medium

    Discovery that ClC-4 promotes copper loading of ceruloplasmin and co-immunoprecipitates with the copper transporter ATP7B revealed a specific role in metal homeostasis distinct from ClC-3.

    Evidence Overexpression of ClC-4 vs. ClC-3 with ceruloplasmin; co-IP with ATP7B; confocal co-localization

    PMID:15057754

    Open questions at the time
    • Loss-of-function validation of copper phenotype not performed
    • Co-IP without reciprocal validation
  5. 2005 High

    Reclassification of ClC-4 from a Cl⁻ channel to a secondary active Cl⁻/H⁺ antiporter — with identification of E211 as the critical proton-coupling glutamate — fundamentally redefined its molecular mechanism.

    Evidence pH measurements near cell surface in Xenopus oocytes; E211A mutagenesis with electrophysiology

    PMID:16034421

    Open questions at the time
    • Transport stoichiometry not directly determined for ClC-4
    • Reconstitution in proteoliposomes not performed
  6. 2006 High

    Mapping an N-terminal ER-retention motif (aa 14–63) explained why ClC-4 localizes to the ER when expressed alone, raising the question of what mechanism reroutes it to endosomes in vivo.

    Evidence Truncation and chimera constructs with confocal imaging and subcellular fractionation in HEK293 and skeletal muscle fibers

    PMID:17023393

    Open questions at the time
    • Partner-dependent re-routing not yet identified
    • ER retention motif sequence determinants not mapped to specific residues
  7. 2008 High

    Identification of an extracellular Zn²⁺ inhibition site involving three consecutive histidines provided the first structural insight into ClC-4 regulation by divalent cations.

    Evidence Xenopus oocyte electrophysiology with systematic histidine mutagenesis and ion substitution

    PMID:18658230

    Open questions at the time
    • Physiological relevance of Zn²⁺ inhibition in endosomal lumen not established
    • No structural data to confirm binding site geometry
  8. 2009 High

    Clcn4-knockout fibroblasts with alkalinized endosomes and impaired transferrin uptake — but normal EGF/lysosome trafficking — genetically confirmed a specific role for ClC-4 in recycling-endosome acidification and iron release.

    Evidence Clcn4-null mouse primary fibroblasts; endosomal pH measurement; transferrin and EGF trafficking assays; deferoxamine rescue

    PMID:19339555

    Open questions at the time
    • In vivo neuronal phenotype not assessed in this study
    • Contribution of ClC-3 compensation not evaluated
  9. 2017 High

    Demonstration that ClC-3 splice variants redirect ClC-4 from the ER to distinct endosomal compartments via heterodimerization resolved the long-standing puzzle of ClC-4's ER retention and established ClC-3/ClC-4 heterodimers as the physiologically relevant species.

    Evidence Co-expression in WT and Clcn3⁻/⁻ astrocytes; clear native gel electrophoresis; confocal imaging

    PMID:28972156

    Open questions at the time
    • Determinants within ClC-3 that dictate sorting destination not mapped
    • Endogenous stoichiometry of heterodimers vs. homodimers in neurons unknown
  10. 2022 High

    Systematic electrophysiological analysis of 59 pathogenic CLCN4 variants established that neurodevelopmental disease arises through mechanistically distinct loss-of-function and gain-of-function mechanisms, explaining clinical heterogeneity.

    Evidence Xenopus oocyte two-electrode voltage-clamp of 59 variants; extended voltage and pH protocols

    PMID:35721313 PMID:36385166

    Open questions at the time
    • Correlation between variant class and clinical severity not fully resolved
    • Effects on ClC-3/ClC-4 heterodimer function not assessed for all variants
  11. 2024 High

    Identification of TMEM9B as a direct interactor that specifically inhibits ClC-3/ClC-4 transport revealed a previously unknown accessory subunit-based regulatory mechanism for endosomal Cl⁻/H⁺ exchange.

    Evidence FLIM-FRET in HEK cells; electrophysiology in Xenopus oocytes and HEK cells; isoform specificity controls (ClC-7, ClC-1 unaffected)

    PMID:39202776

    Open questions at the time
    • TMEM9B stoichiometry and binding interface not determined
    • In vivo significance of TMEM9B regulation not tested
  12. 2025 Medium

    Discovery that certain CLCN4 variants exert dominant-negative effects within ClC-3/ClC-4 heterodimers provided a molecular explanation for severe phenotypes in heterozygous females carrying X-linked mutations.

    Evidence Two-electrode voltage-clamp and whole-cell patch-clamp with bicistronic IRES co-expression of ClC-3 and ClC-4 variants

    PMID:41439993

    Open questions at the time
    • Structural basis of dominant-negative effect unknown
    • Not all pathogenic variants tested for dominant-negative activity
  13. 2025 Medium

    Clcn4 KO mice exhibit autism-like behaviors, abnormal dendritic morphology, and reduced synaptic signaling (SYNAPSIN, PSD95, ERK, CREB phosphorylation), establishing a direct in vivo role for ClC-4 in synaptic plasticity and neural circuit function.

    Evidence Clcn4 KO mice; behavioral testing; Sholl analysis; immunoblot of signaling proteins; cortical neuron culture

    PMID:39863599

    Open questions at the time
    • Causal link between endosomal acidification defect and synaptic signaling changes not established
    • Cell-type-specific requirements for ClC-4 in the brain not delineated

Open questions

Synthesis pass · forward-looking unresolved questions
  • A high-resolution structure of ClC-4 (alone or as a ClC-3/ClC-4 heterodimer) is lacking, and the molecular basis of how endosomal pH changes translate into synaptic and neurodevelopmental dysfunction remains unresolved.
  • No cryo-EM or X-ray structure of ClC-4 or ClC-3/ClC-4 heterodimer
  • Mechanism linking endosomal acidification defect to dendritic and synaptic pathology unclear
  • Native tissue stoichiometry and interactome of ClC-3/ClC-4 heterodimers in neurons undetermined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 5
Localization
GO:0005768 endosome 3 GO:0005783 endoplasmic reticulum 2 GO:0005886 plasma membrane 1
Pathway
R-HSA-1643685 Disease 4 R-HSA-382551 Transport of small molecules 4 R-HSA-5653656 Vesicle-mediated transport 3
Partners
ATP7BCLCN3CLCN5TMEM9B
Complex memberships
ClC-3/ClC-4 heterodimer

Evidence

Reading pass · 18 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2005 ClC-4 functions as a secondary active Cl⁻/H⁺ antiporter (not a classical Cl⁻ channel), transporting protons against their electrochemical gradient coupled to Cl⁻ movement; mutation of the pore glutamate E211A abolishes H⁺ but not Cl⁻ transport, identifying this residue as essential for proton transport. pH measurements near cell surface in Xenopus oocytes; site-directed mutagenesis (E211A) with electrophysiology Nature High 16034421
1999 ClC-4 directly mediates strongly outwardly rectifying anion currents with a NO₃⁻ > Cl⁻ > Br⁻ > I⁻ conductance sequence; point mutations (including E224A in ClC-4) alter voltage dependence and ion selectivity, confirming direct channel-mediated currents. Xenopus oocyte and HEK293 electrophysiology; site-directed mutagenesis The Journal of biological chemistry High 9873029
2003 ClC-4 is expressed in endosomal membranes; antisense-mediated disruption of endogenous ClC-4 acidifies endosomal pH and alters transferrin trafficking; ClC-4 and ClC-5 can be co-immunoprecipitated, suggesting they may function as a channel complex in endosomes. Confocal microscopy; antisense knockdown; endosomal pH measurement; co-immunoprecipitation The Journal of biological chemistry Medium 12746443
2003 ClC-4 exhibits unique pore properties including voltage-dependent unitary conductance (~0.10 pA at +140 mV) and distinct conductivity/permeability sequences for anions, with permeability increasing for anions with lower dehydration energies. Whole-cell patch-clamp recording; variance analysis; ion substitution experiments in tsA201/HEK293 cells Biophysical journal High 12668439
2002 Recombinant human ClC-4 generates a small-conductance (~3 pS), strongly outward-rectifying Cl⁻ channel whose activity requires ATP (with hydrolysis needed for full activity); external acidification inhibits currents with half-maximal inhibition at ~pH 6.19; Ca²⁺ has no effect. Patch-clamp electrophysiology in multiple mammalian cell lines; single-channel recordings; nucleotide substitution experiments The Journal of physiology High 11882671
2001 ClC-4 co-localizes with CFTR in the brush border membrane of intestinal epithelial cells and partially with endosomal markers; antisense knockdown of endogenous ClC-4 reduces Cl⁻ current amplitude by 50%, demonstrating functional expression at the plasma membrane of enterocytes. Confocal and electron microscopy; antisense knockdown; electrophysiology The Journal of biological chemistry Medium 11675385
2004 ClC-4 promotes copper incorporation into ceruloplasmin; ClC-4 overexpression doubles holoCp secretion (more than 4-fold under copper-limiting conditions), while ClC-3 overexpression has no effect; ClC-4 co-immunoprecipitates with ATP7B (Wilson's disease protein) and co-localizes with it in intracellular vesicles. Co-overexpression with ceruloplasmin; gel electrophoresis/immunoblot; co-immunoprecipitation; subcellular fractionation/confocal microscopy Gastroenterology Medium 15057754
2006 Human ClC-4 localizes to the endoplasmic reticulum/sarcoplasmic reticulum (not vesicular structures like ClC-3) when heterologously expressed; a stretch of N-terminal residues (aa 14–63) constitutes a novel motif necessary and sufficient for ER targeting. Heterologous expression in HEK293 and skeletal muscle fibers; subcellular fractionation; truncation and chimera constructs; confocal imaging FASEB journal High 17023393
2008 Zn²⁺ inhibits ClC-4 currents with ~50 µM apparent affinity via an extracellular binding site involving three consecutive histidine residues in an extracellular loop; mutations of these histidines reduce Zn²⁺ inhibition; alterations of transport properties (permeant ions, gating glutamate mutation) also affect Zn²⁺ inhibition. Xenopus oocyte electrophysiology; site-directed mutagenesis of candidate histidine residues; ion substitution Biophysical journal High 18658230
2009 ClC-4-null fibroblasts show alkaline endosomal pH, reduced transferrin (Tfn) receptor-mediated uptake despite slightly increased Tfn receptor surface expression; the iron-release defect (a pH-dependent step) can be rescued by the iron chelator deferoxamine; ClC-4 depletion has no effect on EGFR trafficking to lysosomes, demonstrating a specific role in recycling endosomes. Primary fibroblasts from Clcn4-null mice; endosomal pH measurement; transferrin uptake assays; surface biotinylation; deferoxamine rescue; EGF trafficking comparison Journal of cell science High 19339555
2017 ClC-4 is retained in the ER upon overexpression alone but is sorted to late endosomes/lysosomes or recycling endosomes depending on which ClC-3 splice variant it heterodimerizes with; in Clcn3-null astrocytes, ClC-4 is retained in the ER; native gel electrophoresis shows ClC-4 mostly as monomer with ClC-3–ClC-4 heterodimers being more stable than ClC-4 homodimers. Heterologous expression; confocal imaging in WT and Clcn3⁻/⁻ astrocytes; high-resolution clear native gel electrophoresis; co-expression of ClC-3 splice variants The Journal of biological chemistry High 28972156
2022 Pathogenic CLCN4 missense variants cause either loss-of-function (voltage-dependent activation shifted to more positive voltages) or gain-of-function (disrupted gate allowing inward transport at negative voltages); 15/59 variants showed LOF and 9 showed toxic GOF by electrophysiology. Xenopus oocyte two-electrode voltage-clamp; extended voltage and pH ranges; functional analysis of 59 variants Molecular psychiatry High 36385166
2022 Disease-causing CLCN4 mutations can impair ClC-4 ion transport, alter subcellular trafficking, and/or impair heterodimerization with ClC-3; even subtle functional changes to endosomal Cl⁻/H⁺ exchange cause serious neurological symptoms. Heterologous expression in mammalian cells; patch-clamp electrophysiology; biochemistry; confocal imaging; analysis of 12 CLCN4 variants Frontiers in molecular neuroscience High 35721313
2024 TMEM9B directly interacts with ClC-3 and ClC-4 transporters (demonstrated by FLIM-FRET), and co-expression of TMEM9B dramatically reduces ClC-3 and ClC-4 transporter activity in Xenopus oocytes and HEK cells, while having little effect on ClC-7 or ClC-1, identifying TMEM9B as a specific regulatory accessory subunit for ClC-3/ClC-4. Xenopus oocyte electrophysiology; whole-cell patch-clamp in HEK cells; FLIM-FRET; co-expression studies Life (Basel, Switzerland) High 39202776
2025 Certain pathogenic CLCN4 variants exert dominant-negative effects within ClC-3/ClC-4 heterodimers, suppressing transport activity of the heteromeric complex; this provides a molecular explanation for severe phenotypes in heterozygous females. Two-electrode voltage-clamp in Xenopus oocytes; whole-cell patch-clamp in mammalian cells; bicistronic IRES co-expression of ClC-3 and ClC-4 variants Cells Medium 41439993
2025 CLCN4 variants in human neurons cause early-stage neuronal cell death associated with altered endo-lysosomal dynamics and disrupted autophagic flux; MEG3 lncRNA is downregulated in CLCN4-variant neurons and its restoration rescues cellular defects and neuronal survival. Brain organoids and iPSC-derived neurons with patient CLCN4 variants; transcriptomic profiling; MEG3 rescue experiments; autophagic flux assays bioRxivpreprint Low bio_10.1101_2025.07.16.665078
2025 Clcn4 knockout mice display reduced social interaction, increased repetitive behaviors, abnormal dendritic spine formation, reduced dendritic branching, and decreased phosphorylation of SYNAPSIN, PSD95, ERK, and CREB, as well as reduced CDK5 expression, demonstrating a role for ClC-4 in synaptic plasticity and neuronal morphology. Clcn4 KO mice (exon 5 deletion); behavioral tests; RNA-seq of mouse NPCs; immunoblot; Sholl analysis; cortical neuron culture Translational psychiatry Medium 39863599
2024 The CLCN4 p.(Gly342Arg) variant impairs ClC-4 heterodimerization with ClC-3 and suppresses anion currents; p.(Ile549Leu) and p.(Asp89Asn) shift voltage dependency of transport activation by ~20 mV, with p.(Asp89Asn) constituting a gain-of-transport-function variant, demonstrating that both LOF and GOF ClC-4 variants cause epilepsy and developmental encephalopathy. Patch-clamp electrophysiology; protein biochemistry; confocal fluorescence microscopy in mammalian cells Human genetics Medium 38578438

Source papers

Stage 0 corpus · 32 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2005 Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 376 16034421
1999 Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. The Journal of biological chemistry 208 9873029
2003 The chloride channel ClC-4 contributes to endosomal acidification and trafficking. The Journal of biological chemistry 85 12746443
1995 Different chromosomal localization of the Clcn4 gene in Mus spretus and C57BL/6J mice. Nature genetics 72 7670496
2016 De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females. Molecular psychiatry 57 27550844
2003 Anion permeation in human ClC-4 channels. Biophysical journal 49 12668439
2002 Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells. The Journal of physiology 48 11882671
2001 The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia. The Journal of biological chemistry 47 11675385
2009 Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. Nephron. Physiology 28 19546591
2022 Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition. Molecular psychiatry 27 36385166
2006 The human ClC-4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N-terminus. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 27 17023393
2004 Involvement of chloride channels in hepatic copper metabolism: ClC-4 promotes copper incorporation into ceruloplasmin. Gastroenterology 27 15057754
2021 The molecular and phenotypic spectrum of CLCN4-related epilepsy. Epilepsia 25 33951195
2017 Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments. The Journal of biological chemistry 24 28972156
2009 An essential role for ClC-4 in transferrin receptor function revealed in studies of fibroblasts derived from Clcn4-null mice. Journal of cell science 21 19339555
2011 Clcn4-2 genomic structure differs between the X locus in Mus spretus and the autosomal locus in Mus musculus: AT motif enrichment on the X. Genome research 18 21282478
2008 Insights into the ClC-4 transport mechanism from studies of Zn2+ inhibition. Biophysical journal 16 18658230
2022 Functional Characterization of CLCN4 Variants Associated With X-Linked Intellectual Disability and Epilepsy. Frontiers in molecular neuroscience 13 35721313
2021 Novel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report. BMC pediatrics 12 34479510
2025 Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD. Translational psychiatry 8 39863599
2023 Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families. Frontiers in genetics 8 37359369
2024 TMEM9B Regulates Endosomal ClC-3 and ClC-4 Transporters. Life (Basel, Switzerland) 7 39202776
2023 Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability. Frontiers in neurology 6 37789889
2024 Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy. Human genetics 5 38578438
2024 Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients. Journal of neurology 4 38758281
2024 Experience with the Ketogenic Diet in a Boy with CLCN4 Related Neurodevelopmental Disorder. Balkan journal of medical genetics : BJMG 2 38482266
2023 Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report. Brain & development 2 37271660
2023 Prenatal diagnosis of CLCN4-related neurodevelopmental disorder in fetuses with congenital brain anomalies. Prenatal diagnosis 2 37409888
2023 Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer. Aging 1 37671947
2025 Clinical features and genetic analysis of epilepsy caused by CLCN4 gene mutation: a case report and literature review. Translational pediatrics 0 40800199
2025 Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters. Cells 0 41439993
2023 [Analysis of CLCN4 gene variant in a child with Raynaud-Claes syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 0 37730231